Wednesday, July 8, 2026

Domain Adaptation for IMU Data to Enhance Objective Assessment of Friedreich Ataxia

›
Tran, M., Ranaweera, K., Ngo, T., Pathirana, P., Milne, S., Horne, M., Delatycki, M., & Corben, L. (2026). Domain Adaptation for IMU Dat...

Epigenetic reactivation in Friedreich’s ataxia from benzamides to gene‑targeted chimeras

›
Ansari, F. U., Rojsajjakul, T., Liu, J., Nageshwaran, S. K., & Blair, I. A. (2026). Epigenetic reactivation in Friedreich’s ataxia from ...

Advances in Gene and Cellular Therapy in Friedreich Ataxia

›
Lazaropoulos MP, Lynch DR. Advances in Gene and Cellular Therapy in Friedreich Ataxia. Mol Diagn Ther. 2026 Jun 29. doi: 10.1007/s40291-026-...

Frataxin attenuates endothelial inflammation triggered by engulfment of senescent erythrocytes

›
Xingyi Cheng, Yi Cheng, Chenglin Huang, Tong Wei, Yuetong Guo, Jing Gao, Weili Shen, Frataxin attenuates endothelial inflammation triggered ...
Tuesday, July 7, 2026

Key Interventions in Friedreich's Ataxia and Their Impact on Patient Outcomes: A Systematic Review

›
Sarwinska D, Buchholz M, Iskandar A, Grobe-Einsler M, Klockgether T, Faber J, Michalowsky B. Key Interventions in Friedreich's Ataxia an...
Friday, June 26, 2026

Nrf2 modulates cytosolic and mitochondrial calcium signal

›
Alessandra Preziuso, Artyom Y. Baev, Fozila R. Rustamova, Sharadha Dayalan Naidu, Lauren Millichap, Plamena R. Angelova, Vincenzo Lariccia, ...
Thursday, June 25, 2026

LEXEO THERAPEUTICS ANNOUNCES REGULATORY UPDATE AND REGISTRATIONAL TRIAL DESIGN FOR LX2006 GENE THERAPY IN FRIEDREICH ATAXIA

›
NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, today announced that the Company has finalized the SUNRISE-FA 2 pivotal tria...

Drugging the ferroptotic landscape of Friedreich’s Ataxia: Current paradigms and future directions

›
Cravin G, Cozza G. Drugging the ferroptotic landscape of Friedreich’s Ataxia: Current paradigms and future directions. Ferroptosis Oxid Stre...

Transitional Life Events in Friedreich Ataxia: Differential Age at Onset Perspectives

›
Iskandar, A., Buchholz, M., Sarwinska, D. et al. Transitional Life Events in Friedreich Ataxia: Differential Age at Onset Perspectives. Cere...
Wednesday, June 24, 2026

AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich Ataxia: A Nonrandomized Clinical Trial

›
Crystal RG, Weinsaft JW, Kaminsky SM, et al. AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich Ataxia: A Nonrandomized Clinical...